Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, is pleased to announce that it has signed a distribution agreement for OxC-beta™ Livestock in Thailand with FAITH (Feed and Ingredients Technology Hub), a member of the BIS Group of Companies.
The agreement, which is not exclusive, includes Thailand, Myanmar, Cambodia, Laos, Malaysia, Vietnam and Indonesia, and allows FAITH to immediately distribute in Thailand as well as Myanmar and Cambodia, as both these countries follow Thailand’s regulatory authority, and where Avivagen has already obtained regulatory approval. The introduction to FAITH was arranged by Ms. Jaruwan Sanping, Avivagen’s Thailand-based consultant, and is evidence of the tremendous sales potential of the Asia-Pacific region, with a growing middle class and annual feed consumption of 381mm tones, representing 35.6% of the world’s total.
In conjunction with this agreement, FAITH announced that it has completed a successful trial with OxC-beta™ Livestock on a commercial pig farm in Thailand with one of its customers, and that the trial results met all of its expectations. Thailand is known for its leadership throughout the region for reducing the use of antibiotics in animal feed. The agreement with FAITH demonstrates Avivagen’s ability to provide a much-needed alternative to help alleviate the global problem of antibiotic resistance.